Research at Oslo University Hospital


Oslo University Hospital is a merger of three former university hospitals in Oslo. Biomedical research is one of the hospital's core activities. Research at the hospital is closely interlinked with research undertaken at the University of Oslo. More than 50% of all biomedical research in Norway is published by researchers affiliated with the hospital. Research undertaken cover both basic rsearch, translational research, and clinical research.

Oslo University Hospital has a central role in developing and supporting biomedical research within the South-Eastern Regional Health Authority. The hospital also pursues international research collaborations.


Latest news

Glioma treatment research project headed by Einar Vik-Mo and Iver Langmoen attracts attention

Einar O. Vik-Mo
Einar O. Vik-Mo

A project initiated by post doc Einar Vik-Mo and professor Iver Langmoen from the Department of Neurosurgery at OUS has drawn interest from Norwegian media. The major newspaper Aftenposten has recently presented his project in a feature article entitled "Norwegian physicians tailor make chemotherapy to each tumor".

Prospective isolation of tumour initiating cells is possible using tumour specific antigens. Vik-Mo, Langmoen and collaborators s are currently working on the isolation and characterization of such tumour initiating cells using primary cell cultures, both as floating neurosphere assays and adherent cultures, and combining this with FACS and MACS to prospectively isolate the putative tumour initiating cells.


Karin Cecilie Lødrup Carlsen appointed "Scientist of the Month" by "Helse Sør-Øst" for June 2014

K.C. Lødrup Carlsen
K.C. Lødrup Carlsen

The South-Eastern Norway Regional Health Authority (Helse Sør-Øst) aims to profile ongoing excellent research in the region by calling special attention to a "Scientist of the Month".

For the month of June 2014, this honour went to Karin Cecilie Lødrup Carlsen from the Department of Paediatric Medicine at the Women and Children's Division, Oslo University Hospital.


Department of Cancer Prevention held a public cancer research event for the Røst community


Professors Ragnhild A. Lothe, Guro E. Lind and Rolf Skotheim recently arranged a popular science event for the inhabitants of Røst with support from the mayor of Røst, Tor Andreassen, and the district medical officer, Kjell Arne Helgebostad.




Eight students at Department of Cancer Prevention awarded academic degrees spring 2014

Institute for Cancer Research is strongly involved in education and training of students at the Masters and PhD levels. Recently, four students at the Department of Cancer Prevention were awarded MSc degrees from the Institute for Molecular Biosciences, University of Oslo, and four PhD students from the same department defended their PhD theses this spring at the Faculties of Medicine & Mathematics and Natural Sciences, U of Oslo. Finally, an interfacultary advanced cancer biology course was carried out this spring (see below).

Helmholtz International Fellow Award to Anne-Lise Børresen-Dale

A.-L. Børresen-Dale
A.-L. Børresen-Dale

Anne-Lise Børresen-Dale, head of the Department of Genetics at the Insitute for Cancer Research, has recently been selected for the The Helmholtz International Fellow Award For Excellent Researchers and Science Managers and is welcomed as an honorary member into the Helmholtz community.
Cooperation with the world's best researchers is a key objective of the Helmholtz Association's international activities. To this end, the organisation established the Helmholtz International Fellow Award in 2012, which targets outstanding senior scientists and research managers based outside Germany who have excelled in fields relevant to the Helmholtz Association, including science management at large international research institutions.


King Olav V's cancer research prize for 2014 to Harald A. Stenmark


King Olav V's cancer research prize for 2014 was on June 2nd given to professor Harald A. Stenmark from the Department of Biochemistry at the Divison of Cancer Medicine, Surgery and Transplantation, OUS.

The prestigious prize is distributed annually by the Norwegian Cancer Society, and the winner receives NOK 1.000.000.